ILMN Illumina Inc

Price (delayed)

$139.83

Market cap

$22.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.34

Enterprise value

$23.35B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's debt has decreased by 37% YoY
The quick ratio has grown by 16% YoY and by 3.6% from the previous quarter
Illumina's EPS has surged by 74% YoY but it has decreased by 3.4% QoQ
ILMN's net income has soared by 74% year-on-year but it is down by 3.3% since the previous quarter
The equity has decreased by 13% YoY and by 2.6% from the previous quarter
The company's gross profit fell by 8% YoY

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
158.9M
Market cap
$22.22B
Enterprise value
$23.35B
Valuations
Price to book (P/B)
3.87
Price to sales (P/S)
4.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.18
Earnings
Revenue
$4.5B
EBIT
-$1.04B
EBITDA
-$608M
Free cash flow
$283M
Per share
EPS
-$7.34
Free cash flow per share
$1.79
Book value per share
$36.18
Revenue per share
$28.51
TBVPS
$28.94
Balance sheet
Total assets
$10.11B
Total liabilities
$4.37B
Debt
$2.18B
Equity
$5.75B
Working capital
$1.04B
Liquidity
Debt to equity
0.38
Current ratio
1.66
Quick ratio
1.14
Net debt/EBITDA
-1.86
Margins
EBITDA margin
-13.5%
Gross margin
60.9%
Net margin
-25.8%
Operating margin
-23.7%
Efficiency
Return on assets
-10.6%
Return on equity
-18.7%
Return on invested capital
-23.7%
Return on capital employed
-12.2%
Return on sales
-23.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-0.82%
1 week
3.16%
1 month
-4.7%
1 year
-29.8%
YTD
0.42%
QTD
0.42%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.5B
Gross profit
$2.74B
Operating income
-$1.07B
Net income
-$1.16B
Gross margin
60.9%
Net margin
-25.8%
Illumina's operating margin has soared by 74% YoY but it has decreased by 2.6% from the previous quarter
ILMN's net income has soared by 74% year-on-year but it is down by 3.3% since the previous quarter
The operating income has soared by 74% YoY but it has decreased by 3.5% from the previous quarter
Illumina's net margin has surged by 73% YoY but it has decreased by 2.4% QoQ

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
3.87
P/S
4.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.18
Illumina's EPS has surged by 74% YoY but it has decreased by 3.4% QoQ
The price to book (P/B) is 50% lower than the 5-year quarterly average of 7.8 and 12% lower than the last 4 quarters average of 4.4
The equity has decreased by 13% YoY and by 2.6% from the previous quarter
ILMN's P/S is 57% below its 5-year quarterly average of 11.5 and 21% below its last 4 quarters average of 6.2

Efficiency

How efficient is Illumina business performance
ILMN's return on invested capital has surged by 78% year-on-year
Illumina's return on sales has surged by 75% YoY
The company's return on assets has surged by 67% YoY but it fell by 8% QoQ
The ROE has soared by 63% YoY but it has contracted by 7% from the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 132% more than the total liabilities
The current ratio has grown by 30% YoY
Illumina's total liabilities has decreased by 23% YoY but it has increased by 3.4% from the previous quarter
Illumina's debt is 62% lower than its equity
Illumina's debt has decreased by 37% YoY
The debt to equity is down by 28% year-on-year but it is up by 2.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.